Vireo Growth (VREOF) Cash & Equivalents (2020 - 2026)

Vireo Growth's (VREOF) quarterly Cash & Equivalents came in at $122.4 million in Q1 2026, up 42.0% year-on-year from $86.2 million in Q1 2025, and little changed quarter-over-quarter from $122.5 million in Q4 2025.

Vireo Growth (VREOF) Cash & Equivalents (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Cash & Equivalents across 7 years of filings, most recently posting $122.4 million for Q1 2026.

  • Cash & Equivalents for Q1 2026 came in at $122.4 million, up 42.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $122.4 million (up 42.0% YoY), and the FY2025 annual result was $122.5 million, up 33.73% from the prior year.
  • Cash & Equivalents came in at $122.4 million for Q1 2026 at Vireo Growth, roughly flat from $122.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $122.5 million in Q4 2025 to a low of $7.3 million in Q3 2024.
  • The 5-year median for Cash & Equivalents is $16.0 million (2023), against an average of $46.5 million.
  • Across the five-year window, Cash & Equivalents sank 78.79% in 2022 and surged 1514.58% in 2025, its largest moves.
  • Vireo Growth's Cash & Equivalents stood at $15.1 million in 2022, then gained by 5.38% to $16.0 million in 2023, then jumped by 473.77% to $91.6 million in 2024, then jumped by 33.73% to $122.5 million in 2025, then retreated by 0.08% to $122.4 million in 2026.
  • The last three Cash & Equivalents figures came in at $122.4 million (Q1 2026), $122.5 million (Q4 2025), and $117.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 3.74 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 1.94 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 1.28 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 40.42 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 266.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 428.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 351.55 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 222.27 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 498.58 Mn
10 Vireo Growth - - 59.30 Mn 122.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 122.40 Mn
Dec 31, 2025 122.50 Mn
Sep 30, 2025 117.54 Mn
Jun 30, 2025 106.19 Mn
Mar 31, 2025 86.20 Mn
Dec 31, 2024 91.60 Mn
Sep 30, 2024 7.28 Mn
Jun 30, 2024 11.23 Mn
Mar 31, 2024 12.60 Mn
Dec 31, 2023 15.96 Mn
Sep 30, 2023 13.30 Mn
Jun 30, 2023 11.35 Mn
Mar 31, 2023 10.35 Mn
Dec 31, 2022 15.15 Mn
Sep 30, 2022 21.84 Mn
Jun 30, 2022 16.97 Mn
Mar 31, 2022 8.60 Mn
Dec 31, 2021 15.16 Mn
Sep 30, 2021 11.78 Mn
Jun 30, 2021 20.83 Mn